Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Classification of non-indigenous species based on their impacts: considerations for application in marine management.
Ojaveer H, Galil BS, Campbell ML, Carlton JT, Canning-Clode J, Cook EJ, Davidson AD, Hewitt CL, Jelmert A, Marchini A, McKenzie CH, Minchin D, Occhipinti-Ambrogi A, Olenin S, Ruiz G. Ojaveer H, et al. Among authors: davidson ad. PLoS Biol. 2015 Apr 15;13(4):e1002130. doi: 10.1371/journal.pbio.1002130. eCollection 2015 Apr. PLoS Biol. 2015. PMID: 25875845 Free PMC article.
Deciphering P values: Beware false certainty.
Hewitt CL, Campbell ML, Davidson AD. Hewitt CL, et al. Among authors: davidson ad. Science. 2016 Aug 5;353(6299):551. doi: 10.1126/science.aag3065. Science. 2016. PMID: 27493173 No abstract available.
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses.
Bigotti MG, Klein K, Gan ES, Anastasina M, Andersson S, Vapalahti O, Katajisto P, Erdmann M, Davidson AD, Butcher SJ, Collinson I, Ooi EE, Balistreri G, Brancaccio A, Yamauchi Y. Bigotti MG, et al. Among authors: davidson ad. Antiviral Res. 2024 Apr;224:105837. doi: 10.1016/j.antiviral.2024.105837. Epub 2024 Feb 20. Antiviral Res. 2024. PMID: 38387750 Free article.
In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.
Buzas D, Bunzel AH, Staufer O, Milodowski EJ, Edmunds GL, Bufton JC, Vidana Mateo BV, Yadav SKN, Gupta K, Fletcher C, Williamson MK, Harrison A, Borucu U, Capin J, Francis O, Balchin G, Hall S, Vega MV, Durbesson F, Lingappa S, Vincentelli R, Roe J, Wooldridge L, Burt R, Anderson RJL, Mulholland AJ, Bristol Uncover Group, Hare J, Bailey M, Davidson AD, Finn A, Morgan D, Mann J, Spatz J, Garzoni F, Schaffitzel C, Berger I. Buzas D, et al. Among authors: davidson ad. Antib Ther. 2023 Oct 17;6(4):277-297. doi: 10.1093/abt/tbad024. eCollection 2023 Oct. Antib Ther. 2023. PMID: 38075238 Free PMC article.
123 results